3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Classical hematology
1
Conditions
Breast Neoplasms
65
Neoplasm Metastasis
56
Leukemia, Myeloid, Acute
55
Multiple Myeloma
44
Prostatic Neoplasms
43
Melanoma
43
Lung Neoplasms
39
Colorectal Neoplasms
35
Lymphoma
33
Pancreatic Neoplasms
30
Leukemia, Lymphocytic, Chronic, B-Cell
30
Carcinoma, Non-Small-Cell Lung
29
Myelodysplastic Syndromes
26
Squamous Cell Carcinoma of Head and Neck
25
Lymphoma, Large B-Cell, Diffuse
25
Triple Negative Breast Neoplasms
22
Neoplasms
22
Ovarian Neoplasms
21
Burkitt Lymphoma
21
Lymphoma, Follicular
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Carcinoma, Renal Cell
18
Sarcoma
17
Lymphoma, Mantle-Cell
17
Glioma
17
Uterine Cervical Neoplasms
16
Rectal Neoplasms
16
Leukemia, Myelomonocytic, Chronic
15
Fallopian Tube Neoplasms
15
Stomach Neoplasms
14
Interventions
Melphalan
4
fludarabine
3
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Patient Reported Outcome Measures
2
Mycophenolic Acid
2
Mesna
2
Cyclophosphamide
2
Busulfan
2
Alemtuzumab
2
venetoclax
1
spartalizumab
1
sabatolimab
1
ruxolitinib
1
lintuzumab
1
filanesib
1
Stem Cell Transplantation
1
Sertraline
1
Sampling Studies
1
Metformin
1
Lenalidomide
1
Decitabine
1
Clofarabine
1
CPI-0610
1
Bone Marrow Transplantation
1
Biopsy
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Preleukemia
×
Biopsy
×
Clear all
NCT02452983
2022-06-02
SS1
Baylor College of Medicine
Phase 1
Terminated
14 enrolled